Stock info Karyopharm Therapeutics Inc | Filter  Basic-Info

Karyopharm Therapeutics Inc

The past year was a profitable year for the Karyopharm Therapeutics Inc investors

Over the past year the company' stock lost around 31 percent. The period between August 2011 and August 2016 was a loss-making period for the investors. The stock lost on average 0 percent. Karyopharm Therapeutics Inc's revenues between 2011 and 2015 were very fluctuating and moved between 0,63 million dollars and 0,25 million dollars. Karyopharm Therapeutics Inc's net results between 2011 and 2015 were far from constant and moved between -10,31 million dollars and -118,09 million dollars.

Karyopharm Therapeutics Inc is mostly active in the pharmaceutical sector. The period from 2006 till the end of 2016 the international sector gained around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.

The American company didn't pay out any dividends (in the past 5 years).

Karyopharm Therapeutics Inc financed with relatively a lot of debt

Last year the balance sheet of the American company was worth 215,44 million dollars. The total debt was around 17,07 million dollars. This is 7,92 percent of the total balance sheet. At the end of 2015 the pharmaceutical company's stock was traded with a price/earnings-ratio -11. So the stock' value was -11 times the 2015' earnings per share. We could say that based on her price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the American company's market capitalization equaled around 461,63 million dollars. At the end of 2015 the American company had around 35,62 million stocks listed on the stock exchange(s).

All Karyopharm Therapeutics Inc's financial reports are available here. More information about Karyopharm Therapeutics Inc can be found it's website. .